Repros Therapeutics Inc.® Reports Fourth Quarter and Year End 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. USO
7. STZ
8. CRGY
9. AAPL
10. SPY

Go back to Repros Therapeutics Inc.® Reports Fourth Quarter and Year End 2015 Financial Results

Repros Therapeutics (RPRX) Tops Q4 EPS by 1c

March 14, 2016 9:15 AM EDT

Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27).

The Company had cash and cash equivalents of approximately $21.4 million as of December 31, 2015 as compared to $46.6 million as of December 31, 2014. Net cash of approximately $25.3 million was used in operating activities... More